Gene · 6752
Papers3,968
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 3,968
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Supremacy of nanoparticles in the therapy of chronic myelogenous leukemia. | ADMET DMPK | 2023 | 37937247 | PubTator, text mining | PubMed |
| Tumor-induced Osteomalacia: A Case Report and Etiological Analysis with Literature Review. | Orthop Surg | 2023 | 37933469 | PubTator, text mining | PubMed |
| Engineering CAR-T cells for radiohapten capture in imaging and radioimmunotherapy applications. | Theranostics | 2023 | 37908719 | PubTator, text mining | PubMed |
| Clival Ectopic Pituitary Adenoma Causing Cushing Syndrome. | JCEM Case Rep | 2023 | 37908213 | PubTator, text mining | PubMed |
| Applying HDACis to increase SSTR2 expression and radiolabeled DOTA-TATE uptake: from cells to mice. | Life Sci | 2023 | 37907154 | PubTator, text mining | PubMed |
| Pathogenesis and therapeutic implications of EBV-associated epithelial cancers. | Front Oncol | 2023 | 37901329 | PubTator, text mining | PubMed |
| Immunological role and prognostic value of somatostatin receptor family members in colon adenocarcinoma. | Front Pharmacol | 2023 | 37900156 | PubTator, text mining | PubMed |
| Meningioma animal models: a systematic review and meta-analysis. | J Transl Med | 2023 | 37898750 | PubTator, text mining | PubMed |
| Design, Synthesis, and Biological Evaluation of a Novel [18F]-Labeled Arginine Derivative for Tumor Imaging. | Pharmaceuticals (Basel) | 2023 | 37895948 | PubTator, text mining | PubMed |
| Radiometals in Imaging and Therapy: Highlighting Two Decades of Research. | Pharmaceuticals (Basel) | 2023 | 37895931 | PubTator, text mining | PubMed |
| Immunohistochemical Glucagon-like Peptide-1 Receptor Expression in Human Insulinomas. | Int J Mol Sci | 2023 | 37894845 | PubTator, text mining | PubMed |
| Early short-term effects on catecholamine levels and pituitary function in patients with pheochromocytoma or paraganglioma treated with [177Lu]Lu-DOTA-TATE therapy. | Front Endocrinol (Lausanne) | 2023 | 37886645 | PubTator, text mining | PubMed |
| Multiple ossified intracranial and spinal meningiomas: a rare case report and literature review. | Front Neurol | 2023 | 37885473 | PubTator, text mining | PubMed |
Study protocol of LANTana: a phase Ib study to investigate epigenetic modification of somatostatin receptor-2 with ASTX727 to improve therapeutic outcome with [177Lu]Lu-DOTA-TATE in patients with metastatic neuroendocrine tumours, UK. | BMJ Open | 2023 | 37879695 | PubTator, text mining | PubMed |
| Initial Findings on the Use of [225Ac]Ac-DOTATATE Therapy as a Theranostic Application in Patients with Neuroendocrine Tumors. | Mol Imaging Radionucl Ther | 2023 | 37870290 | PubTator, text mining | PubMed |
| Prognostic risk of immune-associated signature in the microenvironment of brain gliomas. | Front Genet | 2023 | 37867596 | PubTator, text mining | PubMed |
| A case report of bilateral lateral ventricle calcified pseudoneoplasm of the neuraxins. | Chin Neurosurg J | 2023 | 37853457 | PubTator, text mining | PubMed |
| Somatostatin receptor expression and clinical outcome of multilineage pituitary tumours expressing PIT1 and SF1. | Endocr Connect | 2023 | 37851558 | PubTator, text mining | PubMed |
| Challenging Tumor Heterogeneity with HER2, p16 and Somatostatin Receptor 2 Expression in a Case of EBV-Associated Lymphoepithelial Carcinoma of the Salivary Gland. | Head Neck Pathol | 2023 | 37847488 | PubTator, text mining | PubMed |
| 68 Ga-DOTATATE PET/CT of Metastatic Lymphoepithelial Carcinoma of Parotid Gland. | Clin Nucl Med | 2023 | 37844551 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6752/papers?page=21